I think Ma is completely genuine on the buying. The R&R around insider buying and company buybacks is simply insane and overwhelming. He referenced me thru their legal counsel to the documentation and I never made it all the way through. It is extremely more complicated then it was 15 years ago when I last really went throught it. The company buyback isnt going to happen unless volume substantially increases. However, once that happens - it probably wont be necessary at least not to the degree now.
The personal buying is not straoghtforward either. Even a salary deferral changes dramaticallyfor a small company an insiders. Every event they are waiting on is material to this stock. They cant start or end in between events without exposure. If you heard Ma answer that question on the online presentation - it was one of the few times his voice really changed. There was a natural inflection that showed real tension. I may be reading too much into it but it is consistent with what I have read and understand. So - I do take his word for it.
If you look at where most of the volume was prior to the run to $0.74 - it was considerably higher than where we are today which is a good sign.
I also feel we are on the verge of a reversal/run (or else I wouldnt be buying aggressively). I dont see $2-3 unless there is major, major CMS changes in preferential class for angina and CHF combined with a dedicated uptick in EECP sales domestically. I can see tbis running over $1 on a very strong quarter but dont see it holding. If the volume/price rises slowly and steadily and we continue to attract long term holders - than it might hold. However, I think we will likely see another spike and drop. Really will depend on what type of voluke we see leading up to earnings.
Recent VASO News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/10/2024 09:08:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 09:05:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/23/2024 08:04:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:01:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:00:52 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 08/02/2024 05:47:51 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 07/26/2024 01:37:49 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:01:18 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 03/06/2024 09:58:30 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/11/2023 07:10:05 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM